Nexilis AG
  • Home
  • Platforms
    • Immediate Stabilisation System (ISS)
    • Extra Cellular Matrix (ECM) Coating
    • Bisphosponate Coating (BCP)
  • About us
    • Operative Team
    • Member of Clinical & Medical Advisory Board
    • Board of Directors
  • Contact
  • Terms of Use & privacy statement
  • Home
  • Platforms
    • Immediate Stabilisation System (ISS)
    • Extra Cellular Matrix (ECM) Coating
    • Bisphosponate Coating (BCP)
  • About us
    • Operative Team
    • Member of Clinical & Medical Advisory Board
    • Board of Directors
  • Contact
  • Terms of Use & privacy statement

​BISPHOSPHONATE COATING PLATFORM (BCP)

Goal

  • To improve long-term stabilisation of orthopaedic implants

Concept

  • Coating technology that allows coating of implants with bisphosphonates
  • Leading to significantly improved long-term stabilisation of implants as bisphosphonates block osteoclastic activity

Technology

  • Simply and easy-to-use coating process
  • Allowing deposition of bisphosphonates on all implant surfaces
  • Technology platform can be used as a drug delivery system

USP

  • Platform technology without any change of original implants
  • One-phase system: carrier = drug
  • No linker, no toxic side effects
  • Release can be adjusted
  • Independent of the substrate material
  • Gamma & EtO sterilisable
  • Low-cost technology
Bild

Schematic diagram of Nexilis propietary one phase system coating
© 2020 Nexilis AG | Imprint | Disclaimer | Contact